Literature DB >> 9717757

Management of intra-ocular foreign bodies impacting or embedded in the retina.

S Pavlovic1, K G Schmidt, Z Tomic, M Dzinic.   

Abstract

PURPOSE: To identify both the clinical features of eyes suffering penetrating ocular injury with intra-ocular foreign bodies (FB) impacting or embedded in the retina and the results of surgical outcome and complication rates.
METHODS: Thirty-eight consecutive cases of penetrating ocular injuries with intra-ocular FB impacting or embedded in the retina were retrospectively analysed.
RESULTS: The FB were metallic in 30 eyes (78.9%; 19 ferromagnetic) and were non-metallic in eight eyes (21.1%). Magnetic extraction was performed in 17 cases (44.7%) and instrumental extraction was performed in 21 cases (55.3%). In two cases, pars plana vitrectomy and FB removal was combined with penetrating keratoplasty, temporary keratoprosthesis and anterior segment reconstruction because of severe explosive injury to the eye. At the final postoperative examination, 32 eyes (84.2%) had completely attached retinas. Visual acuity (VA) improved postoperatively in 18 eyes (47.4%). A final VA of 0.5 or better was achieved in nine of 23 eyes (39.1%) with FB in the peripheral retina and in one of 15 eyes (6.7%) with posterior pole and/or optic nerve head involvement. There was no difference in the final VA regarding the time elapsed between trauma and the removal of the FB.
CONCLUSION: The late anatomical and functional outcome in eyes with penetrating ocular injury and FB impacting or embedded in the retina is mostly uncertain, despite immediate and complex surgery. Final anatomical and functional outcome in the present study was influenced by location and extent of the initial damage to the posterior pole. The time that had elapsed between trauma and removal of the FB did not influence final visual function.

Entities:  

Mesh:

Year:  1998        PMID: 9717757     DOI: 10.1111/j.1442-9071.1998.tb01319.x

Source DB:  PubMed          Journal:  Aust N Z J Ophthalmol        ISSN: 0814-9763


  7 in total

1.  Ferrous intraocular foreign bodies retained in the posterior segment: management options and results.

Authors:  V Mester; F Kuhn
Journal:  Int Ophthalmol       Date:  1998       Impact factor: 2.031

2.  Prognosis of penetrating eye injuries with posterior segment intraocular foreign body.

Authors:  Zsuzsanna Szijártó; Valéria Gaál; Bálint Kovács; Ferenc Kuhn
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-08-04       Impact factor: 3.117

3.  Late onset of rhegmatogenous retinal detachments after successful posterior segment intraocular foreign body removal.

Authors:  D J Weissgold; P Kaushal
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

4.  Outcomes of surgery for posterior segment intraocular foreign bodies--a retrospective review of 17 years of clinical experience.

Authors:  Louisa Wickham; Wen Xing; Catey Bunce; Paul Sullivan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-12       Impact factor: 3.117

5.  Visual outcome of pars plana vitrectomy with intraocular foreign body removal through sclerocorneal tunnel and sulcus-fixated intraocular lens implantation as a single procedure, in cases of metallic intraocular foreign body with traumatic cataract.

Authors:  Santosh K Mahapatra; Nageswar G Rao
Journal:  Indian J Ophthalmol       Date:  2010 Mar-Apr       Impact factor: 1.848

6.  23-gauge vitrectomy with intraocular foreign body removal via the limbus: an alternative approach for select cases.

Authors:  Ramandeep Singh; Swapnil Bhalekar; Mangat R Dogra; Amod Gupta
Journal:  Indian J Ophthalmol       Date:  2014-06       Impact factor: 1.848

7.  Intraoperative Macula Protection by Perfluorocarbon Liquid for the Metallic Intraocular Foreign Body Removal during 23-Gauge Vitrectomy.

Authors:  Robert Rejdak; Tomasz Choragiewicz; Joanna Moneta-Wielgos; Dominika Wrzesinska; Dorota Borowicz; Matteo Forlini; Anselm G Jünemann; Katarzyna Nowomiejska
Journal:  J Ophthalmol       Date:  2017-05-02       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.